Serveur d'exploration Hippolyte Bernheim

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Physico-chemistry of lipopolysaccharides and inflammatory response : role of lipoproteins

Identifieur interne : 000110 ( Hal/Corpus ); précédent : 000109; suivant : 000111

Physico-chemistry of lipopolysaccharides and inflammatory response : role of lipoproteins

Auteurs : Wahib Sali

Source :

RBID : Hal:tel-01134149

Descripteurs français

English descriptors

Abstract

LPS is a potent bacterial pro-inflammatory agent, consisting of hydrophilic, polysaccharide part and of a lipid A which is considered like active moiety. Nevertheless, the O chain of LPS influences their aggregation in aqueous media. Therefore, our goal has been to determine the role of O chain on the LPS biological and physiopathological effects. Our work was organized according to three main axes, and led to the following findings :- development of a new LPS assay by LC-MS/MS. The combination of this new technique with LAL test allowed us to calculate an inactivation ratio which reflects the ability of host organism to inactivate LPS, especially through their transfer to HDL by PLTP. The ratio could be useful in predicting outcome of high risk patients.- the length of O chain modulates LPS-induced inflammation. Above their critical aggregation concentration, LPS form aggregates with an architecture and physiochemical properties dependent on their O chain. Both parameters determine LPS biological activity and their metabolism.- development of an innovative dual labelling of LPS as a new tool to explore LPS elimination pathway : the reverse LPS transport. This work brings evidence that the physiopathological effects of LPS depend on two parameters : their biological activity and their metabolism. Any strategy of research or therapeutic targeting LPS should take into account their molecular structure, their aggregability and the relation between the both parameters, which are major determinants of their biological activity and their metabolism.

Url:

Links to Exploration step

Hal:tel-01134149

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Physico-chemistry of lipopolysaccharides and inflammatory response : role of lipoproteins</title>
<title xml:lang="fr">Physico-chimie des lipopolysaccharides et réponse inflammatoire : rôle des lipoprotéines</title>
<author>
<name sortKey="Sali, Wahib" sort="Sali, Wahib" uniqKey="Sali W" first="Wahib" last="Sali">Wahib Sali</name>
<affiliation>
<hal:affiliation type="laboratory" xml:id="struct-27738" status="OLD">
<orgName>Lipides - Nutrition - Cancer (U866)</orgName>
<orgName type="acronym">LNC</orgName>
<date type="start">2007-01-01</date>
<date type="end">2016-12-31</date>
<desc>
<address>
<addrLine>Université de Bourgogne - Faculte de medecine - 7, boulevard Jeanne d'Arc - BP 87900 - 21079 Dijon Cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://inserm-u866.u-bourgogne.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-300270" type="direct"></relation>
<relation name="U866" active="#struct-303623" type="direct"></relation>
<relation name="U866" active="#struct-415469" type="direct"></relation>
<relation name="U866" active="#struct-482629" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300270" type="direct">
<org type="institution" xml:id="struct-300270" status="VALID">
<orgName>Université de Bourgogne</orgName>
<orgName type="acronym">UB</orgName>
<desc>
<address>
<addrLine>Maison de l'université - Esplanade Érasme - BP 27877 - 21078 Dijon cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.u-bourgogne.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U866" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="U866" active="#struct-415469" type="direct">
<org type="institution" xml:id="struct-415469" status="VALID">
<idno type="IdRef">13996634X</idno>
<orgName>AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement</orgName>
<date type="start">2009-03-01</date>
<desc>
<address>
<addrLine>26 Boulevard du Dr Petitjean - BP 87999 - 21079 Dijon cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.agrosupdijon.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U866" active="#struct-482629" type="direct">
<org type="institution" xml:id="struct-482629" status="OLD">
<idno type="IdRef">026636344</idno>
<orgName>Ecole Nationale Supérieure de Biologie Appliquée à la Nutrition et à l'Alimentation de Dijon</orgName>
<orgName type="acronym">ENSBANA</orgName>
<date type="start">1975-01-01</date>
<date type="end">2009-02-28</date>
<desc>
<address>
<addrLine>Campus de Montmuzard, 21100 Dijon</addrLine>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:tel-01134149</idno>
<idno type="halId">tel-01134149</idno>
<idno type="halUri">https://tel.archives-ouvertes.fr/tel-01134149</idno>
<idno type="url">https://tel.archives-ouvertes.fr/tel-01134149</idno>
<date when="2014-12-16">2014-12-16</date>
<idno type="wicri:Area/Hal/Corpus">000110</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Physico-chemistry of lipopolysaccharides and inflammatory response : role of lipoproteins</title>
<title xml:lang="fr">Physico-chimie des lipopolysaccharides et réponse inflammatoire : rôle des lipoprotéines</title>
<author>
<name sortKey="Sali, Wahib" sort="Sali, Wahib" uniqKey="Sali W" first="Wahib" last="Sali">Wahib Sali</name>
<affiliation>
<hal:affiliation type="laboratory" xml:id="struct-27738" status="OLD">
<orgName>Lipides - Nutrition - Cancer (U866)</orgName>
<orgName type="acronym">LNC</orgName>
<date type="start">2007-01-01</date>
<date type="end">2016-12-31</date>
<desc>
<address>
<addrLine>Université de Bourgogne - Faculte de medecine - 7, boulevard Jeanne d'Arc - BP 87900 - 21079 Dijon Cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://inserm-u866.u-bourgogne.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-300270" type="direct"></relation>
<relation name="U866" active="#struct-303623" type="direct"></relation>
<relation name="U866" active="#struct-415469" type="direct"></relation>
<relation name="U866" active="#struct-482629" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300270" type="direct">
<org type="institution" xml:id="struct-300270" status="VALID">
<orgName>Université de Bourgogne</orgName>
<orgName type="acronym">UB</orgName>
<desc>
<address>
<addrLine>Maison de l'université - Esplanade Érasme - BP 27877 - 21078 Dijon cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.u-bourgogne.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U866" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="U866" active="#struct-415469" type="direct">
<org type="institution" xml:id="struct-415469" status="VALID">
<idno type="IdRef">13996634X</idno>
<orgName>AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement</orgName>
<date type="start">2009-03-01</date>
<desc>
<address>
<addrLine>26 Boulevard du Dr Petitjean - BP 87999 - 21079 Dijon cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.agrosupdijon.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U866" active="#struct-482629" type="direct">
<org type="institution" xml:id="struct-482629" status="OLD">
<idno type="IdRef">026636344</idno>
<orgName>Ecole Nationale Supérieure de Biologie Appliquée à la Nutrition et à l'Alimentation de Dijon</orgName>
<orgName type="acronym">ENSBANA</orgName>
<date type="start">1975-01-01</date>
<date type="end">2009-02-28</date>
<desc>
<address>
<addrLine>Campus de Montmuzard, 21100 Dijon</addrLine>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
</affiliation>
</author>
</analytic>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="mix" xml:lang="en">
<term>Aggregation</term>
<term>Innate immunity</term>
<term>LC-MS/MS assay</term>
<term>Lipoprotein</term>
<term>PhosphoLipid Transfer Protein (PLTP)</term>
</keywords>
<keywords scheme="mix" xml:lang="fr">
<term>Agrégation</term>
<term>Dosage LC-MS/MS</term>
<term>Immunité innée</term>
<term>Inflammation</term>
<term>Lipide A</term>
<term>Lipopolysaccharide (LPS)</term>
<term>Lipoprotéine</term>
<term>Monocyte</term>
<term>Protéine de Transfert des Phospholipides (PLTP)</term>
<term>TLR4 (Toll-Like Receptor 4)</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">LPS is a potent bacterial pro-inflammatory agent, consisting of hydrophilic, polysaccharide part and of a lipid A which is considered like active moiety. Nevertheless, the O chain of LPS influences their aggregation in aqueous media. Therefore, our goal has been to determine the role of O chain on the LPS biological and physiopathological effects. Our work was organized according to three main axes, and led to the following findings :- development of a new LPS assay by LC-MS/MS. The combination of this new technique with LAL test allowed us to calculate an inactivation ratio which reflects the ability of host organism to inactivate LPS, especially through their transfer to HDL by PLTP. The ratio could be useful in predicting outcome of high risk patients.- the length of O chain modulates LPS-induced inflammation. Above their critical aggregation concentration, LPS form aggregates with an architecture and physiochemical properties dependent on their O chain. Both parameters determine LPS biological activity and their metabolism.- development of an innovative dual labelling of LPS as a new tool to explore LPS elimination pathway : the reverse LPS transport. This work brings evidence that the physiopathological effects of LPS depend on two parameters : their biological activity and their metabolism. Any strategy of research or therapeutic targeting LPS should take into account their molecular structure, their aggregability and the relation between the both parameters, which are major determinants of their biological activity and their metabolism.</div>
</front>
</TEI>
<hal api="V3">
<titleStmt>
<title xml:lang="en">Physico-chemistry of lipopolysaccharides and inflammatory response : role of lipoproteins</title>
<title xml:lang="fr">Physico-chimie des lipopolysaccharides et réponse inflammatoire : rôle des lipoprotéines</title>
<author role="aut">
<persName>
<forename type="first">Wahib</forename>
<surname>Sali</surname>
</persName>
<idno type="halauthorid">971922</idno>
<affiliation ref="#struct-27738"></affiliation>
</author>
<editor role="depositor">
<persName>
<forename>ABES</forename>
<surname>STAR</surname>
</persName>
<email type="md5">f5aa7f563b02bb6adbba7496989af39a</email>
<email type="domain">abes.fr</email>
</editor>
</titleStmt>
<editionStmt>
<edition n="v1" type="current">
<date type="whenSubmitted">2015-03-23 09:12:07</date>
<date type="whenModified">2018-02-11 01:14:24</date>
<date type="whenReleased">2015-03-23 11:01:49</date>
<date type="whenProduced">2014-12-16</date>
<date type="whenEndEmbargoed">2015-03-23</date>
<ref type="file" target="https://tel.archives-ouvertes.fr/tel-01134149/document">
<date notBefore="2015-03-23"></date>
</ref>
<ref type="file" subtype="author" n="1" target="https://tel.archives-ouvertes.fr/tel-01134149/file/these_A_SALI_Wahib_2014.pdf">
<date notBefore="2015-03-23"></date>
</ref>
</edition>
<respStmt>
<resp>contributor</resp>
<name key="131274">
<persName>
<forename>ABES</forename>
<surname>STAR</surname>
</persName>
<email type="md5">f5aa7f563b02bb6adbba7496989af39a</email>
<email type="domain">abes.fr</email>
</name>
</respStmt>
</editionStmt>
<publicationStmt>
<distributor>CCSD</distributor>
<idno type="halId">tel-01134149</idno>
<idno type="halUri">https://tel.archives-ouvertes.fr/tel-01134149</idno>
<idno type="halBibtex">sali:tel-01134149</idno>
<idno type="halRefHtml">Biochimie [q-bio.BM]. Université de Bourgogne, 2014. Français. 〈NNT : 2014DIJOS051〉</idno>
<idno type="halRef">Biochimie [q-bio.BM]. Université de Bourgogne, 2014. Français. 〈NNT : 2014DIJOS051〉</idno>
</publicationStmt>
<seriesStmt>
<idno type="stamp" n="STAR">STAR - Dépôt national des thèses électroniques</idno>
<idno type="stamp" n="UNIV-BOURGOGNE">Université de Bourgogne</idno>
<idno type="stamp" n="INSERM">INSERM - Institut national de la santé et de la recherche médicale</idno>
<idno type="stamp" n="LNC-UMR866" p="UNIV-BOURGOGNE">Lipides Nutrition Cancer - UMR866</idno>
<idno type="stamp" n="AGREENIUM">Archive ouverte en agrobiosciences</idno>
<idno type="stamp" n="ENSBANA" p="AGROSUP-DIJON">École Nationale Supérieure de Biologie Appliquée à la Nutrition et à l'Alimentation ENSBANA</idno>
<idno type="stamp" n="AGROSUP-DIJON">AGROSUP-DIJON</idno>
</seriesStmt>
<notesStmt></notesStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Physico-chemistry of lipopolysaccharides and inflammatory response : role of lipoproteins</title>
<title xml:lang="fr">Physico-chimie des lipopolysaccharides et réponse inflammatoire : rôle des lipoprotéines</title>
<author role="aut">
<persName>
<forename type="first">Wahib</forename>
<surname>Sali</surname>
</persName>
<idno type="halauthorid">971922</idno>
<affiliation ref="#struct-27738"></affiliation>
</author>
</analytic>
<monogr>
<idno type="nnt">2014DIJOS051</idno>
<imprint>
<date type="dateDefended">2014-12-16</date>
</imprint>
<authority type="institution">Université de Bourgogne</authority>
<authority type="school">École doctorale Environnements, Santé (Dijon ; Besançon ; 2012-....)</authority>
<authority type="supervisor">Laurent Lagrost</authority>
<authority type="supervisor">Thomas Gautier</authority>
<authority type="jury">David Masson [Président]</authority>
<authority type="jury">Catherine Desrumaux [Rapporteur]</authority>
<authority type="jury">Sophie Visvikis-Siest [Rapporteur]</authority>
<authority type="jury">Maryse Guérin</authority>
</monogr>
</biblStruct>
</sourceDesc>
<profileDesc>
<langUsage>
<language ident="fr">French</language>
</langUsage>
<textClass>
<keywords scheme="author">
<term xml:lang="en">Aggregation</term>
<term xml:lang="en">LC-MS/MS assay</term>
<term xml:lang="en">PhosphoLipid Transfer Protein (PLTP)</term>
<term xml:lang="en">Lipoprotein</term>
<term xml:lang="en">Innate immunity</term>
<term xml:lang="fr">Dosage LC-MS/MS</term>
<term xml:lang="fr">Agrégation</term>
<term xml:lang="fr">Protéine de Transfert des Phospholipides (PLTP)</term>
<term xml:lang="fr">Lipoprotéine</term>
<term xml:lang="fr">Inflammation</term>
<term xml:lang="fr">Monocyte</term>
<term xml:lang="fr">TLR4 (Toll-Like Receptor 4)</term>
<term xml:lang="fr">Immunité innée</term>
<term xml:lang="fr">Lipopolysaccharide (LPS)</term>
<term xml:lang="fr">Lipide A</term>
</keywords>
<classCode scheme="halDomain" n="sdv.bbm.bc">Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biomolecules [q-bio.BM]</classCode>
<classCode scheme="halTypology" n="THESE">Theses</classCode>
</textClass>
<abstract xml:lang="en">LPS is a potent bacterial pro-inflammatory agent, consisting of hydrophilic, polysaccharide part and of a lipid A which is considered like active moiety. Nevertheless, the O chain of LPS influences their aggregation in aqueous media. Therefore, our goal has been to determine the role of O chain on the LPS biological and physiopathological effects. Our work was organized according to three main axes, and led to the following findings :- development of a new LPS assay by LC-MS/MS. The combination of this new technique with LAL test allowed us to calculate an inactivation ratio which reflects the ability of host organism to inactivate LPS, especially through their transfer to HDL by PLTP. The ratio could be useful in predicting outcome of high risk patients.- the length of O chain modulates LPS-induced inflammation. Above their critical aggregation concentration, LPS form aggregates with an architecture and physiochemical properties dependent on their O chain. Both parameters determine LPS biological activity and their metabolism.- development of an innovative dual labelling of LPS as a new tool to explore LPS elimination pathway : the reverse LPS transport. This work brings evidence that the physiopathological effects of LPS depend on two parameters : their biological activity and their metabolism. Any strategy of research or therapeutic targeting LPS should take into account their molecular structure, their aggregability and the relation between the both parameters, which are major determinants of their biological activity and their metabolism.</abstract>
<abstract xml:lang="fr">Le LPS est un puissant agent pro-inflammatoire bactérien, dont la partie lipide A est considérée comme le principe actif. Néanmoins, la chaîne O des LPS influence leur agrégation en solution aqueuse. Notre but a été de déterminer le rôle de la chaîne O sur les effets biologiques et physiopathologiques des LPS.Nos travaux, menés selon trois axes stratégiques complémentaires, ont donné lieu aux avancées suivantes :- développement d'un dosage innovant des LPS par LC-MS/MS et d'un ratio d'inactivation des LPS sur la base d'une utilisation combinée dudit dosage et du test LAL. Ce ratio traduit la capacité d'un organisme hôte à inactiver les LPS, notamment par leur transfert aux HDL par la PLTP. Ce ratio pourrait être utile dans l'évaluation des patients à haut risque.- la longueur de la chaîne O module l'inflammation induite par les LPS. Au-delà de leur concentration d'agrégation critique, les LPS forment des agrégats dotés d’une architecture et de propriétés physico-chimiques dépendant de leur chaîne O. Ces deux paramètres déterminent l'activité biologique des LPS et leur métabolisme ;- développement d'un double marquage innovant des LPS confirmant leur voie principale d'élimination : le transport inverse du LPS. Ce travail définit donc les effets physiopathologiques induits par les LPS comme résultant de deux composantes : leur activité biologique et leur métabolisme. Toute stratégie de recherche ou thérapeutique ciblant les LPS, devrait donc prendre en compte leur structure moléculaire, leur agrégabilité et la relation entre ces deux paramètres, déterminants majeurs de l'activité biologique des LPS et de leur métabolisme.</abstract>
</profileDesc>
</hal>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/BernheimV1/Data/Hal/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000110 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Hal/Corpus/biblio.hfd -nk 000110 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Psychologie
   |area=    BernheimV1
   |flux=    Hal
   |étape=   Corpus
   |type=    RBID
   |clé=     Hal:tel-01134149
   |texte=   Physico-chemistry of lipopolysaccharides and inflammatory response : role of lipoproteins
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Mar 5 17:33:33 2018. Site generation: Thu Apr 29 15:49:51 2021